EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The forgotten population: Early‐onset Alzheimer's in people with Down syndrome

Michelle Cristina Oliveira

Alzheimer's & Dementia · 2026-04 · 22 (4)

DOI: 10.1002/alz.71311 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 27.04.2026. Verfasst von Michelle Cristina Oliveira. Beteiligte Einrichtung: Institute of Psychiatry (IPq), LIM27, University of São Paulo (USP), São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Alzheimer Disease, Down Syndrome. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent decades, Alzheimer's disease has increasingly been discussed through narratives of prevention, resilience, and delayed onset. For individuals with Down syndrome, however, Alzheimer's disease is not a distant possibility, but an almost predictable consequence of increased longevity. The substantial rise in life expectancy in this population represents one of the greatest achievements of modern medicine. At the same time, it has exposed a profound biological vulnerability, as most individuals with Down syndrome will develop Alzheimer's disease‐related neuropathology decades earlier than the general population. Although Down syndrome constitutes the most common genetic cause of Alzheimer's disease, these individuals remain largely excluded from prevention strategies, clinical trials, and global dementia agendas. This Viewpoint argues that such persistent invisibility does not reflect a lack of scientific relevance, but rather a systemic failure to align biological certainty with ethical responsibility. By highlighting the unique trajectory of Alzheimer's disease in Down syndrome, as well as the social, familial, and caregiving implications of early cognitive decline, this article calls for a necessary shift in perspective: from longevity celebrated as an endpoint to longevity recognized as an obligation to ensure inclusion, dignity, and meaningful support. If efforts to confront Alzheimer's disease are to be genuine, they must begin by including those who have lived with its burden the longest, often in silence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDown SyndromeHumansAge of OnsetLife Expectancy

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid precursor proteinbiomarkersdementia preventiondown syndromeethics in researchinclusion

Autor:innen und Institutionen

  • Institute of Psychiatry (IPq), LIM27, University of São Paulo (USP), São Paulo, São Paulo, Brazil.

Zitieren

APA

Oliveira, M. C. (2026). The forgotten population: Early‐onset Alzheimer's in people with Down syndrome. Alzheimer's & Dementia, 22(4). https://doi.org/10.1002/alz.71311

Vancouver

Oliveira MC. The forgotten population: Early‐onset Alzheimer's in people with Down syndrome. Alzheimer's & Dementia. 2026;22(4). doi:10.1002/alz.71311

BibTeX
@article{Oliveira2026,
  author = {Oliveira, Michelle Cristina},
  title = {The forgotten population: Early‐onset Alzheimer's in people with Down syndrome},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {4},
  doi = {10.1002/alz.71311}
}
Kostenlos starten →